Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh. [electronic resource]
Producer: 20170720Description: e0005635 p. digitalISSN:- 1935-2735
- Adolescent
- Adult
- Amphotericin B -- administration & dosage
- Antiprotozoal Agents -- administration & dosage
- Bangladesh
- Child
- Child, Preschool
- Drug Therapy, Combination
- Female
- Humans
- Leishmaniasis, Visceral -- drug therapy
- Male
- Middle Aged
- Paromomycin -- administration & dosage
- Phosphorylcholine -- administration & dosage
- Recurrence
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.